Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Acquisition

27 Sep 2010 07:00

RNS Number : 3178T
PZ CUSSONS PLC
27 September 2010
 

 

27 September 2010

 

PZ Cussons Plc

 

 

ACQUISITION OF ST TROPEZ HOLDINGS LIMITED

 

PZ Cussons Plc, a leading consumer products group in Europe, Asia and Africa, announces the acquisition of the entire issued share capital of St Tropez Holdings Limited ("St Tropez") from UK private equity group LDC for a consideration of £62.5m in cash (on a cash and debt free basis).

 

St Tropez is the UK's leading sunless tanning product range consisting of lotions, mousses, sprays and other products serving consumers who wish to achieve a safe, natural looking tan without the dangers of sun bathing or sun beds.

 

Over 80% of St Tropez's sales are within the UK with Australia and the US also growing markets for the brand. Distribution in the UK is mainly into Boots, Superdrug, Debenhams, Sainsbury's, House of Fraser and John Lewis, as well as through major salons.

 

St Tropez's retail product range comprises approximately 30 products organised across three core categories (Self Tan, Gradual Tan and Wash Off) and complemented by tan optimising products. All manufacturing is outsourced to third parties.

 

Revenue and earnings before depreciation, amortisation, interest and tax for the year ended 31 July 2010 were £20.7m and £7.4m respectively. As at 31 July 2010, St Tropez Holdings Limited had gross assets of £48.1m, including £42.1m of goodwill.

 

The business is being acquired on a cash and debt free basis from cash and existing facilities, and is expected to be earnings enhancing in the current financial year.

 

Alex Kanellis, Chief Executive of PZ Cussons Plc, said:

 

"The acquisition of the St Tropez brand represents an excellent strategic opportunity for PZ Cussons and further strengthens our portfolio of 'masstige' brands which includes The Sanctuary and Charles Worthington. We see good growth opportunities, both in the UK and overseas, particularly by linking the strategy to that of The Sanctuary spa brand.

 

Following this acquisition our balance sheet remains strong giving us flexibility for further investment opportunities as they arise."

 

Michelle Feeney, Chief Executive of St Tropez, said:

 

"I am thrilled that St Tropez is going into such a great home. PZ Cussons offers a synergistic opportunity for growth particularly in conjunction with The Sanctuary and will add the scaleability that the brand needs to become a truly international player."

 

 

- Ends -

 

 

An analyst's conference call will be hosted by Brandon Leigh, Finance Director, at 8:30am today. Please contact Giles Robinson at Hogarth on 020 7645 3988 for details.

 

 

For further information contact:

 

PZ Cussons Plc Tel: 0161 435 1016

Brandon Leigh

 

Hogarth Tel: 020 7357 9477

John Olsen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDQLFLBKFXBBE
Date   Source Headline
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.